Researchers at the University of East Anglia say they have developed the world's first accurate blood test to diagnose ME.
They examined blood samples from 47 patients with severe ME/CFS and 61 healthy adults and discovered "a unique pattern" that appeared consistently in people with ME/CFS and not the healthy controls. From this, they developed the test and reported a 92% sensitivity (likelihood of a test being positive if that patient has the condition.
However, whilst acknowledging the research as an "interesting development" in biomarker research for ME/CFS, other researchers have offered cautionary responses to the results.
Prof Chris Ponting, Principal Investigator for DecodeME, has flagged the need for the test to be fully validated better-designed studies and said some of the claims made by the research team were "premature". He also referenced the likely expensive nature of the test - likely about £1,000.
You can read the full publication, here.
Action for ME share the view that this study does indeed appear encouraging and could prove to be a useful starting point for future research into blood-based diagnostic biomarkers.
It is also important to note that the researchers did highlight the limitations of the research, calling it a "proof of concept" study.
As such, we note the following:
Given these limitations, further research into this area of diagnostics is required before we can conclusively say that we do have an accurate blood test for diagnosing ME.